UK guidelines on the management of iron deficiency in pregnancy

TLDR

Iron deficiency affects over 2 billion people worldwide, is common in both developing and developed countries, and requires effective management to prevent adverse maternal outcomes such as the need for red‑cell transfusion. This guideline offers clear, simple recommendations for diagnosing, treating, and preventing iron deficiency during pregnancy and the postpartum period. It is the first UK guideline on the topic and may be applicable to other developed nations, though it does not address public‑health measures such as helminth control or food fortification. The guidance may not suit all patients, and individual circumstances may necessitate alternative approaches.

Abstract

Summary Iron deficiency is the most common deficiency state in the world, affecting more than 2 billion people globally. Although it is particularly prevalent in less‐developed countries, it remains a significant problem in the developed world, even where other forms of malnutrition have already been almost eliminated. Effective management is needed to prevent adverse maternal and pregnancy outcomes, including the need for red cell transfusion. The objective of this guideline is to provide healthcare professionals with clear and simple recommendations for the diagnosis, treatment and prevention of iron deficiency in pregnancy and the postpartum period. This is the first such guideline in the UK and may be applicable to other developed countries. Public health measures, such as helminth control and iron fortification of foods, which can be important to developing countries, are not considered here. The guidance may not be appropriate to all patients and individual patient circumstances may dictate an alternative approach.